Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics

Background. Glioma prognosis depends on isocitrate dehydrogenase (IDH) mutation status. We aimed to predict the IDH status of gliomas from preoperative MR images using a fully automated hybrid approach with convolutional neural networks (CNNs) and radiomics. Methods. We reviewed 1166 preoperative MR images of gliomas (grades II-IV) from Severance Hospital (n = 856), Seoul National University Hospital (SNUH; n = 107), andThe Cancer Imaging Archive (TCIA; n = 203). The Severance set was subdivided into the development (n = 727) and internal test (n = 129) sets. Based on T1 postcontrast, T2, and fluid-attenuated inversion recovery images, a fully automated model was developed that comprised a CNN for tumor segmentation (Model 1) and CNN-based classifier for IDH status prediction (Model 2) that uses a hybrid approach based on 2D tumor images and radiomic features from 3D tumor shape and loci guided by Model 1. The trained model was tested on internal (a subset of the Severance set) and external (SNUH and TCIA) test sets. Results. The CNN for tumor segmentation (Model 1) achieved a dice coefficient of 0.86-0.92 across datasets. Our hybrid model achieved accuracies of 93.8%, 87.9%, and 78.8%, with areas under the receiver operating characteristic curves of 0.96, 0.94, and 0.86 and areas under the precision-recall curves of 0.88, 0.82, and 0.81 in the internal test, SNUH, and TCIA sets, respectively. Conclusions. Our fully automated hybrid model demonstrated the potential to be a highly reproducible and generalizable tool across different datasets for the noninvasive prediction of the IDH status of gliomas.

Automated summary

This study developed a fully automated hybrid model using convolutional neural networks and radiomics to noninvasively predict the IDH status of gliomas. The model showed high accuracy and reproducibility across different datasets.